Metraipolis › archive › dc_5a065337f0df

Somatostatin and Its Analogues as Second-Line Treatments in Non-Neoplastic Conditions — Europe PMC PMID:42123401

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42123401
DOI
10.3390/ijms27093816
License (as archived)
solo-consultazione
Archived
2026-11-03T06:49:25.727Z
SHA-256 of the archived text
223d7df24312d3fa11ca5571edb6454c6b514e083ff695e0643179d372254597
Stable URL of this page
https://metraipolis.com/documento/dc_5a065337f0df

How to cite

Somatostatin and Its Analogues as Second-Line Treatments in Non-Neoplastic Conditions — Europe PMC PMID:42123401 — Europe PMC (en), https://europepmc.org/article/MED/42123401 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5a065337f0df (Metraipolis archive dc_5a065337f0df, sha256 223d7df24312d3fa11ca5571edb6454c6b514e083ff695e0643179d372254597)
BibTeX
@misc{dc5a065337f0df,
  title = {Somatostatin and Its Analogues as Second-Line Treatments in Non-Neoplastic Conditions — Europe PMC PMID:42123401},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42123401},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5a065337f0df; sha256 223d7df24312d3fa11ca5571edb6454c6b514e083ff695e0643179d372254597},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42123401. Agents can read the archived copy with the MCP tool read_document.